Fed hike: tea leaves now suggest first rate hike won't occur before 1Q23. That's the first quarter of 2023. That's more than a year from now. No rate increases all next year (2022): tea leaves.
SRE: beats by one penny; beats on revenue; shares; extends losses in pre-market trading;
Pre-market: records from earlier this week are holding in pre-market
- three major US equity indices all in the green
- selected tickers:
- MPC: down slightly at close yesterday; flat pre-market;
- AAPL: down a bit at close yesterday; up slightly this morning;
- UNP: down almost one percent yesterday (ouch -- profit taking); today, up a bit;
- SRE: down yesterday; down more today;
- OKE: down yesterday; up a bit
- CLR: down 5% yesterday; up 1.32% in pre-market trading today
- DVN: up 1% yesterday; up another 1.3% now
- XLNX: on a tear; up 3.43% yesterday; up another 1.85% in pre-market trading; might XLNX hit $200 today?
- oral anti-covid drugs
- huge breakthrough: will affect other viral diseases
- anti-covid drugs tested on unvaccinated patients only
- comparison with ivermectin not mentioned
- MRK: up yesterday; down now; first to announce drug; earlier this week;
- PFE: down yesterday; up over 8% in pre-market trading; announced very effective drug overnight;
Covid-19: are folks paying attention. Huge strides in anti-viral research and results being reported. Huge. Previously posted on the blog: Covid-19: many, many silver linings to this dark cloud. Overall: something "positive" for humanity.
No comments:
Post a Comment